Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study

BACKGROUND: The aim of the present study was to examine the cytostatic effects of cold atmospheric plasma (CAP) on different head and neck squamous carcinoma (HNSCC) cell lines either in isolation or in combination with low dose cisplatin. The effect of CAP treatment was investigated by using three...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Teresa F., Probst, Florian A., Troeltzsch, Matthias, Schwenk-Zieger, Sabina, Zimmermann, Julia L., Morfill, Gregor, Becker, Sven, Harréus, Ulrich, Welz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245296/
https://www.ncbi.nlm.nih.gov/pubmed/35768853
http://dx.doi.org/10.1186/s13005-022-00322-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245296/
https://www.ncbi.nlm.nih.gov/pubmed/35768853
http://dx.doi.org/10.1186/s13005-022-00322-5

Ejemplares similares